PAX6 and non-small cell lung carcinoma: Chemoresistance is usually accompanied by metastasis, which inhibits the efficiency of current cancer therapies.42 Our results confirm the role of PAX6 in both tumor cells and animals in stimulating NSCLC resistance to cisplatin treatment by regulating stem cell transformation.